{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:24:55Z","timestamp":1787502295694,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s10840-014-9966-z","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T04:02:02Z","timestamp":1422676922000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400\u00a0mg twice daily for 12\u00a0weeks on atrial fibrillation burden in subjects with permanent pacemakers"],"prefix":"10.1007","volume":"42","author":[{"given":"Michael D.","family":"Ezekowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Ellenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"DiMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoly","family":"Kaszala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Boddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Geba","family":"P.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"9966_CR1","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., Johnston, S. C., Kasner, S. E., Kittner, S. J., Mitchell, P. H., Rich, M. W., Richardson, D., Schwamm, L. H., Wilson, J. A., & on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. (2014). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke, 45, 2160\u20132236.","journal-title":"Stroke"},{"key":"9966_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005344-200302000-00007","volume":"41","author":"P Gautier","year":"2003","unstructured":"Gautier, P., Guillemare, E., Marion, A., Bertrand, J. P., Tourneur, Y., & Nisato, D. (2003). Electrophysiologic characterization of dronedarone in guinea pig ventricular cells. Journal of Cardiovascular Pharmacology, 41, 191\u2013202.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9966_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(95)00130-D","volume":"279","author":"D Hodeige","year":"1995","unstructured":"Hodeige, D., Heyndrickx, J. P., Chatelain, P., & Manning, A. (1995). SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs. European Journal of Pharmacology, 279, 25\u201332.","journal-title":"European Journal of Pharmacology"},{"key":"9966_CR4","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/01.CIR.100.22.2276","volume":"100","author":"W Sun","year":"1999","unstructured":"Sun, W., Sarma, J. S., & Singh, B. N. (1999). Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: comparison with amiodarone. Circulation, 100, 2276\u20132281.","journal-title":"Circulation"},{"issue":"Suppl 2","key":"9966_CR5","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1540-8167.2006.00583.x","volume":"17","author":"FT Wegener","year":"2006","unstructured":"Wegener, F. T., Ehrlich, J. R., & Hohnloser, S. H. (2006). Dronedarone: an emerging agent with rhythm- and rate-controlling effects. Journal of Cardiovascular Electrophysiology, 17(Suppl 2), S17\u2013S20.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"9966_CR6","unstructured":"(2012). Multaq [package insert]. Bridgewater, NJ: sanofi-aventis U.S. LLC."},{"key":"9966_CR7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","volume":"360","author":"SH Hohnloser","year":"2009","unstructured":"Hohnloser, S. H., Crijns, H. J., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009). Effect of dronedarone on cardiovascular events in atrial fibrillation. New England Journal of Medicine, 360, 668\u2013678.","journal-title":"New England Journal of Medicine"},{"key":"9966_CR8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","volume":"357","author":"BN Singh","year":"2007","unstructured":"Singh, B. N., Connolly, S. J., Crijns, H. J., Roy, D., Kowey, P. R., Capucci, A., Radzik, D., Aliot, E. M., & Hohnloser, S. H. (2007). Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. New England Journal of Medicine, 357, 987\u2013999.","journal-title":"New England Journal of Medicine"},{"key":"9966_CR9","unstructured":"(2008). Pacerone [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc."},{"key":"9966_CR10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1586\/erc.09.14","volume":"7","author":"S Krishnamoorthy","year":"2009","unstructured":"Krishnamoorthy, S., & Lip, G. Y. (2009). Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone. Expert Review of Cardiovascular Therapy, 7, 473\u2013481.","journal-title":"Expert Review of Cardiovascular Therapy"},{"key":"9966_CR11","first-page":"B3","volume":"1","author":"DG Wyse","year":"2004","unstructured":"Wyse, D. G. (2004). Overview of endpoints in atrial fibrillation studies. Heart Rhythm, 1, B3\u20137. discussion.","journal-title":"Heart Rhythm"},{"issue":"Suppl H","key":"9966_CR12","doi-asserted-by":"crossref","first-page":"H55","DOI":"10.1093\/eurheartj\/sun028","volume":"10","author":"AJ Camm","year":"2008","unstructured":"Camm, A. J., & Reiffel, J. A. (2008). Defining endpoints in clinical trials on atrial fibrillation. European Heart Journal, 10(Suppl H), H55\u2013H78.","journal-title":"European Heart Journal"},{"key":"9966_CR13","doi-asserted-by":"crossref","first-page":"B36","DOI":"10.1016\/j.hrthm.2004.04.005","volume":"1","author":"EL Pritchett","year":"2004","unstructured":"Pritchett, E. L. (2004). Symptomatic arrhythmia recurrence as an outcome in clinical trials of antiarrhythmic drug therapy. Heart Rhythm, 1, B36\u2013B40.","journal-title":"Heart Rhythm"},{"key":"9966_CR14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","volume":"352","author":"BN Singh","year":"2005","unstructured":"Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., Lewis, H. D., Jr., Raisch, D. W., & Ezekowitz, M. D. (2005). Amiodarone versus sotalol for atrial fibrillation. New England Journal of Medicine, 352, 1861\u20131872.","journal-title":"New England Journal of Medicine"},{"key":"9966_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1540-8167.2001.00121.x","volume":"12","author":"WF Kaemmerer","year":"2001","unstructured":"Kaemmerer, W. F., Rose, M. S., & Mehra, R. (2001). Distribution of patients\u2019 paroxysmal atrial tachyarrhythmia episodes: implications for detection of treatment efficacy. Journal of Cardiovascular Electrophysiology, 12, 121\u2013130.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"9966_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1540-8167.2002.00303.x","volume":"13","author":"LA Shehadeh","year":"2002","unstructured":"Shehadeh, L. A., Liebovitch, L. S., & Wood, M. A. (2002). Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators: implications for assessing antiarrhythmic therapies. Journal of Cardiovascular Electrophysiology, 13, 303\u2013309.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"9966_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10840-011-9636-3","volume":"34","author":"MD Ezekowitz","year":"2012","unstructured":"Ezekowitz, M. D., Nagarakanti, R., Lubinski, A., Bandman, O., Canafax, D., Ellis, D. J., Milner, P. G., Ziola, M., Thibault, B., & Hohnloser, S. H. (2012). A randomized trial of budiodarone in paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 34, 1\u20139.","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"key":"9966_CR18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ahj.2004.06.032","volume":"149","author":"GC Flaker","year":"2005","unstructured":"Flaker, G. C., Belew, K., Beckman, K., Vidaillet, H., Kron, J., Safford, R., Mickel, M., & Barrell, P. (2005). Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal, 149, 657\u2013663.","journal-title":"American Heart Journal"},{"key":"9966_CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., Morillo, C. A., Carlson, M., Themeles, E., Kaufman, E. S., & Hohnloser, S. H. (2012). Subclinical atrial fibrillation and the risk of stroke. New England Journal of Medicine, 366, 120\u2013129.","journal-title":"New England Journal of Medicine"},{"key":"9966_CR20","doi-asserted-by":"crossref","first-page":"B52","DOI":"10.1016\/j.hrthm.2004.03.075","volume":"1","author":"AM Gillis","year":"2004","unstructured":"Gillis, A. M. (2004). Rhythm control in atrial fibrillation: endpoints for device-based trials. Heart Rhythm, 1, B52\u2013B57.","journal-title":"Heart Rhythm"},{"key":"9966_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/B:CEPR.0000023138.85821.63","volume":"7","author":"DE Euler","year":"2003","unstructured":"Euler, D. E., & Friedman, P. A. (2003). Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial. Cardiac Electrophysiology Review, 7, 355\u2013358.","journal-title":"Cardiac Electrophysiology Review"},{"key":"9966_CR22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1540-8167.2002.00542.x","volume":"13","author":"AM Gillis","year":"2002","unstructured":"Gillis, A. M., & Morck, M. (2002). Atrial fibrillation after DDDR pacemaker implantation. Journal of Cardiovascular Electrophysiology, 13, 542\u2013547.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"9966_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jacc.2003.08.027","volume":"43","author":"CW Israel","year":"2004","unstructured":"Israel, C. W., Gronefeld, G., Ehrlich, J. R., Li, Y. G., & Hohnloser, S. H. (2004). Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. Journal of the American College of Cardiology, 43, 47\u201352.","journal-title":"Journal of the American College of Cardiology"},{"key":"9966_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/eurheartj\/ehi059","volume":"26","author":"L Padeletti","year":"2005","unstructured":"Padeletti, L., Santini, M., Boriani, G., Botto, G., Capucci, A., Gulizia, M., Ricci, R., Spampinato, A., Pieragnoli, P., Warman, E., Vimercati, M., & Grammatico, A. (2005). Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. European Heart Journal, 26, 165\u2013172.","journal-title":"European Heart Journal"},{"key":"9966_CR25","doi-asserted-by":"crossref","first-page":"B64","DOI":"10.1016\/j.hrthm.2004.04.010","volume":"1","author":"R Mehra","year":"2004","unstructured":"Mehra, R., Ziegler, P., & Koehler, J. (2004). Diagnostic information in implantable devices that pertain to endpoints in atrial fibrillation studies. Heart Rhythm, 1, B64\u2013B69.","journal-title":"Heart Rhythm"},{"key":"9966_CR26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0735-1097(03)00780-0","volume":"42","author":"MD Carlson","year":"2003","unstructured":"Carlson, M. D., Ip, J., Messenger, J., Beau, S., Kalbfleisch, S., Gervais, P., Cameron, D. A., Duran, A., Val-Mejias, J., Mackall, J., & Gold, M. (2003). A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). Journal of the American College of Cardiology, 42, 627\u2013633.","journal-title":"Journal of the American College of Cardiology"},{"key":"9966_CR27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/hc3401.095039","volume":"104","author":"PA Friedman","year":"2001","unstructured":"Friedman, P. A., Dijkman, B., Warman, E. N., Xia, H. A., Mehra, R., Stanton, M. S., & Hammill, S. C. (2001). Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation, 104, 1023\u20131028.","journal-title":"Circulation"},{"key":"9966_CR28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.102.7.736","volume":"102","author":"AM Gillis","year":"2000","unstructured":"Gillis, A. M., Connolly, S. J., Lacombe, P., Philippon, F., Dubuc, M., Kerr, C. R., Yee, R., Rose, M. S., Newman, D., Kavanagh, K. M., Gardner, M. J., Kus, T., & Wyse, D. G. (2000). Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. Circulation, 102, 736\u2013741.","journal-title":"Circulation"},{"key":"9966_CR29","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0735-1097(03)00426-1","volume":"41","author":"MA Lee","year":"2003","unstructured":"Lee, M. A., Weachter, R., Pollak, S., Kremers, M. S., Naik, A. M., Silverman, R., Tuzi, J., Wang, W., Johnson, L. J., & Euler, D. E. (2003). The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. Journal of the American College of Cardiology, 41, 1926\u20131932.","journal-title":"Journal of the American College of Cardiology"}],"updated-by":[{"DOI":"10.1007\/s10840-015-0001-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:00:00Z","timestamp":1428710400000}}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-014-9966-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-014-9966-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-014-9966-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:53:37Z","timestamp":1553626417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-014-9966-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["9966"],"URL":"https:\/\/doi.org\/10.1007\/s10840-014-9966-z","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}